XTX Topco’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,541
| Closed | -$90.8K | – | 2820 |
|
|
2024
Q4 | $90.8K | Sell |
2,541
-11,349
| -82% | -$406K | 0.01% | 1777 |
|
|
2024
Q3 | $656K | Buy |
13,890
+9,033
| +186% | +$427K | 0.05% | 631 |
|
|
2024
Q2 | $244K | Buy |
4,857
+3,515
| +262% | +$177K | 0.02% | 1091 |
|
|
2024
Q1 | $150K | Buy |
+1,342
| New | +$150K | 0.02% | 1262 |
|
|
2023
Q4 | – | Sell |
-3,169
| Closed | -$101K | – | 1912 |
|
|
2023
Q3 | $101K | Buy |
+3,169
| New | +$101K | 0.02% | 1183 |
|
|
2023
Q2 | – | Sell |
-1,830
| Closed | -$188K | – | 1666 |
|
|
2023
Q1 | $188K | Sell |
1,830
-3,486
| -66% | -$358K | 0.04% | 977 |
|
|
2022
Q4 | $779K | Buy |
5,316
+2,782
| +110% | +$408K | 0.17% | 140 |
|
|
2022
Q3 | $428K | Buy |
2,534
+985
| +64% | +$166K | 0.11% | 305 |
|
|
2022
Q2 | $179K | Buy |
1,549
+1,146
| +284% | +$132K | 0.07% | 495 |
|
|
2022
Q1 | $40K | Sell |
403
-63
| -14% | -$6.25K | 0.02% | 608 |
|
|
2021
Q4 | $72K | Buy |
+466
| New | +$72K | 0.04% | 520 |
|
|
2021
Q3 | – | Sell |
-582
| Closed | -$197K | – | 927 |
|
|
2021
Q2 | $197K | Buy |
+582
| New | +$197K | 0.07% | 570 |
|